Find uplifting stories about heroes, innovations, and solutions
20 results for "glp-1 medication"
New research shows that people who lost the most weight on GLP-1 medications like Ozempic dramatically reduced their risk of serious health problems. Those who shed at least 15% of their body weight saw sleep apnea risk drop by 69% and kidney disease risk fall by 30%.
Scientists have found two promising methods to help people maintain their weight loss after stopping diets or GLP-1 medications like Wegovy. New research shows a daily pill and a probiotic supplement can both help prevent the frustrating cycle of weight regain.
New research challenges concerns that popular GLP-1 medications like Wegovy and Zepbound cause excessive muscle loss. The findings offer reassurance to millions considering or using these breakthrough weight-loss treatments.
A new study linking weight loss drugs to bone loss made headlines, but experts say the real story is far more hopeful. Simple steps like strength training and eating enough protein can protect your bones during weight loss.
Amazon's One Medical is bringing weight-loss drug treatment into primary care offices nationwide, offering patients a safer alternative as demand for medications like Ozempic surges. The move addresses growing concerns about patients receiving improper care from standalone telehealth providers.
New research reveals that GLP-1 medications like Wegovy improve heart and liver health even in patients who don't lose weight. The discovery could help millions more people access these life-changing drugs.
Millions of Americans now have a new option for weight management that doesn't require needles or strict meal planning. The FDA just approved Foundayo, a once-daily pill that can be taken anytime with or without food.
Millions of Americans seeking weight loss help just got a more convenient option. The FDA approved a new daily pill that works like popular injections but without needles or strict timing rules.
A new weight-loss pill that can be taken any time of day just won FDA approval, making treatment easier for millions of Americans. The once-daily tablet offers a needle-free alternative starting at $149 monthly.
A groundbreaking VA study found that GLP-1 medications like Ozempic may reduce substance use disorders across alcohol, opioids, nicotine, and other drugs. For veterans battling addiction alongside diabetes, these findings could change everything.
A massive study of 600,000 veterans found that GLP-1 medications, commonly prescribed for weight loss and diabetes, cut addiction death rates in half. The drugs also reduced the risk of developing substance abuse problems by up to 25% across multiple substances.
Weight loss medications like Ozempic and Mounjaro are showing remarkable promise in fighting addiction to all major substances, from alcohol to opioids. A study of over 600,000 veterans reveals these drugs reduce substance use disorders by blocking the cravings that fuel addiction.
New research suggests GLP-1 medications may help treat alcohol, opioid, and drug addictions by quieting cravings in the brain. A study of 600,000 veterans found fewer ER visits and deaths across all substance types.
A groundbreaking study of 600,000 veterans shows GLP-1 medications like Ozempic dramatically reduce substance use disorders and cut drug-related deaths in half. The discovery could revolutionize how we treat addiction.
ShopRite is giving free wellness kits to customers filling their first weight-loss medication prescription, complete with diet guides, protein samples, and grocery coupons. The East Coast grocery chain is meeting customers where they are as one in eight Americans now takes these medications.
A groundbreaking Harvard study reveals that people with type 2 diabetes who combine GLP-1 medications with healthy habits slash their heart attack and stroke risk by nearly half. The research shows modern medicine works best when paired with old-fashioned healthy living.
Doctors at Mayo Clinic are successfully pairing weight loss surgery with medications like Ozempic to help patients overcome obesity. This combined approach offers new hope for people who need more support than one treatment alone can provide.
Millions of Americans have lost significant weight using GLP-1 medications like Ozempic and Wegovy, but keeping it off requires a smart, sustainable plan. Here's the hopeful science behind maintaining your success.
A biotech company is launching with a groundbreaking mission: using GLP-1 medications to treat substance use disorders instead of weight loss. Baseline Therapeutics could open new hope for millions struggling with addiction.
Prostate cancer patients can now join a groundbreaking trial testing three simple strategies to protect their hearts while receiving lifesaving hormone therapy. City of Hope researchers are comparing intermittent fasting, GLP-1 medication, and heart-healthy lifestyle guidelines to keep patients healthier through treatment.